Euro-GASP external quality assessment scheme for Neisseria gonorrhoeae antimicrobial susceptibility testing
External quality assessment (EQA) is an essential part of any laboratory-based surveillance system, allowing for the monitoring of performance and comparability of results from participating laboratories, identification of potential issues, and deployment of resources and training where necessary.
Developing a reporting system for the surveillance of HIV drug resistance in Europe
A pilot project was carried out to investigate the feasibility of HIVDR surveillance in EU/EEA countries and to make recommendations for the design and implementation of a potential future HIVDR surveillance system at the European level.
The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2017
The data on antimicrobial resistance in zoonotic and indicator bacteria in 2017, submitted by 28 EU Member States (MSs), were jointly analysed by EFSA and ECDC. Resistance in zoonotic Salmonella and Campylobacter from humans, animals and food, and resistance in indicator Escherichia coli as well as meticillin-resistant Staphylococcus aureus in animals and food were addressed, and temporal trends assessed.
External quality assessment of laboratory performance – European Antimicrobial Resistance Surveillance Network (EARS-Net), 2017
This report provides an analysis of the external quality assessment (EQA) performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2017.
Rapid risk assessment: Multidrug-resistant Staphylococcus epidermidis
This rapid risk assessment addresses the public health risk associated with a previously unrecognised international spread of near pandrug-resistant strains of S. epidermidis as a cause of infection in several countries including EU Member States.
Healthcare-associated pneumonia in acute care hospitals in European union/European economic area countries: An analysis of data from a point prevalence survey, 2011 to 2012
Walter, J., Haller, S., Quinten, C., Kärki, T., Zacher, B., Eckmanns, T., Abu Sin, M., Plachouras, D., Kinross, P., Suetens, C., Strauss, R., Mertens, K., Dobreva, E., Budimir, A., Hadjiloucas, A., Prattingerová, J., Kristensen, B., Monnet, D.L., Märtin, P., Lyytikäinen, O., Giard, M., Piening, B., Kritsotakis, E.I., Kurcz, A., Gudlaugsson, Ó., Burns, K., Moro, M.L., Dumpis, U., Ašembergienė, J., Heisbourg, E., Xuereb, D., Hopmans, T., Sorknes, N.K., Deptuła, A., Paiva, J.-A., Serban, R., Litvová, S., Kolman, J., Lozano, J., Struwe, J., Hopkins, S., Doherty, L., Reilly, J.S., Harrison, W.
Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic survey
Harris, S.R., Cole, M.J., Spiteri, G., Sánchez-Busó, L., Golparian, D., Jacobsson, S., Goater, R., Abudahab, K., Yeats, C.A., Bercot, B., Borrego, M.J., Crowley, B., Stefanelli, P., Tripodo, F., Abad, R., Aanensen, D.M., Unemo, M., Azevedo, J., Balla, E., Barbara, C., Bergheim, T., Borrego, M.J., Bremer, V., Buder, S., Maikanti-Charalambous, P., Chisholm, S., Cowan, S., Crowley, B., Crucitti, T., Diez, M., Dudás, M., Eastick, K., Goubard, A., Haller, M., Hauksdóttir, G.S., Hoffmann, S., Hughes, G., Igoe, D., Jeverica, S., Klavs, I., Kløvstad, H., Kohl, P., Konte, V., Linde, I., Mavcutko, V., Melillo, J.M., Pakarna, G., Pavlik, P., Pieridou, D., La Ruche, G., Sigmundsdóttir, G., Soteriou, S., Stary, A., Stefanelli, P., Suligoi, B., Truska, P., Tzelepi, E., Unemo, M., Van Benthem, B., Van Dam, A., Vazquez, J., Velicko, I., Verbrugge, R.
Rapid risk assessment: Candida auris in healthcare settings – Europe
This rapid risk assessment update appraises the risk for spread of C. auris in hospitals in the European Union and European Economic Area (EU/EEA) countries
Networking of Public Health Microbiology Laboratories Bolsters Europe's Defenses against Infectious Diseases
Albiger, B., Revez, J., Leitmeyer, K.C., Struelens, M.J.
ECDC, EFSA and EMA Joint Scientiﬁc Opinion on a list of outcome indicators as regards surveillance of antimicrobial resistance and antimicrobial consumption in humans and food-producing animals
ECDC, EFSA and EMA have jointly established a list of harmonised outcome indicators to assist EU Member States in assessing their progress in reducing the use of antimicrobials and antimicrobial resistance (AMR) in both humans and food-producing animals.